Much of the research and clinical efforts have focused on PIK3CA/p110α but are starting to include PIK3CB/p110β in light of its association with loss of PTEN, the most frequent genetic alteration in endometrial carcinomas. This evidence concerns the gene PIK3CA and endometrial carcinoma.